Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies’ websites

Objective To describe how Italian medical societies interact with pharmaceutical and medical device industries through an analysis of the information available on their websites. Design Cross sectional study. Setting Italy. Participants 154 medical societies registered with the Italian Federation of Medical-Scientific Societies. Main outcome measures Indicators of industry sponsorship (presence of industry sponsorship in the programme of the last medical societies’ annual conference; presence of manufacturers’ logos on the homepage; presence of industry sponsorship of satellite symposia during the last annual conference). Results 131 Italian medical societies were considered. Of these, 4.6% had an ethical code covering relationships with industry on their websites, while 45.6% had a statute that mentioned the issue of conflict of interest and 6.1% published the annual financial report. With regard to industry sponsorship, 64.9% received private sponsorship for their last conference, 29.0% had manufacturers’ logos on their webpage, while 35.9% had industry-sponsored satellite symposia at their last conference. The presence of an ethical code on the societies’ websites was associated with both an increased risk of industry sponsorship of the last conference (relative risk (RR) 1.22, 95% CIs 1.01 to 1.48 after adjustment) and of conferences and/or satellite symposia (RR 1.22, 95% CIs 1.02 to 1.48 after adjustment) but not with the presence of manufacturers’ logos on the websites (RR 1.79, 95% CIs 0.66 to 4.82 after adjustment). No association was observed with the other indicators of governance and transparency. Conclusions This survey shows that industry sponsorship of Italian medical societies’ conferences is common, while the presence of a structured regulatory system is not. Disclosure of the amount of industry funding to medical societies is scarce. The level of transparency therefore needs to be improved and the whole relationship between medical societies and industry should be further disciplined in order to avoid any potential for conflict of interest.

[1]  P. Vercellini,et al.  Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey , 2016, BMJ Open.

[2]  Michael M. Okuji,et al.  Patient Protection and Affordable Care Act , 2015 .

[3]  Shoshannah A. Pearlman The Patient Protection and Affordable Care Act , 2013, Journal of the American Psychiatric Nurses Association.

[4]  S. Herring,et al.  Conflict of interest and professional medical associations: the North American Spine Society experience. , 2013, The spine journal : official journal of the North American Spine Society.

[5]  R. Griggs,et al.  American Academy of Neurology policy on pharmaceutical and device industry support , 2012, Neurology.

[6]  Daylian M. Cain,et al.  The unintended consequences of conflict of interest disclosure. , 2012, JAMA.

[7]  J. Schofferman The medical-industrial complex, professional medical associations, and continuing medical education. , 2011, Pain medicine.

[8]  Wei Zhou,et al.  Ethical management of conflict of interest: proposed standards for academic surgical societies. , 2011, Journal of the American College of Surgeons.

[9]  M. Dalsing Industry working with physicians through professional medical associations. , 2011, Journal of vascular surgery.

[10]  B. Wilson Continuing medical education programs being placed under closer scrutiny , 2010, Canadian Medical Association Journal.

[11]  David B. Resnik,et al.  Conflict of Interest in Medical Research, Education, and Practice , 2010, Environmental Health Perspectives.

[12]  M. Camilleri,et al.  Perspective: Conflict of Interest and Professional Organizations: Considerations and Recommendations , 2010, Academic medicine : journal of the Association of American Medical Colleges.

[13]  Marilyn J. Field,et al.  Conflict of Interest in Medical Research, Education, and Practice , 2009 .

[14]  C. Deangelis,et al.  Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. , 2009, JAMA.

[15]  A. Pisacane Rethinking continuing medical education , 2008, BMJ : British Medical Journal.

[16]  M. Steinman,et al.  Is continuing medical education a drug-promotion tool?: YES. , 2007, Canadian family physician Medecin de famille canadien.

[17]  J. Kassirer Professional Societies and Industry Support: What Is the Quid Pro Quo? , 2007, Perspectives in biology and medicine.

[18]  S. Coyle PhysicianIndustry Relations. Part 2: Organizational Issues , 2002, Annals of Internal Medicine.

[19]  J Lexchin,et al.  Interactions between physicians and the pharmaceutical industry: what does the literature say? , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[20]  D F Thompson,et al.  Understanding financial conflicts of interest. , 1993, The New England journal of medicine.

[21]  C. Goodman Council of Medical Specialty Societies , 1988 .